Cheminformatics Market is predicted to reach USD ~20.11 billion at a CAGR of ~15.5% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Cheminformatics Market”

Market Highlights

The global cheminformatics market is accounted to register a CAGR of 15.5% during the forecast period and is estimated to reach USD 20.11 billion by 2032.

Cheminformatics is a new information technology (IT) branch focusing on gathering, storing, analyzing, and modifying chemical data. The chemical data includes small molecule formulas, structures, characteristics, spectra, and biological & industrial activities. Cheminformatics helps in the definition of archival data processes and the representation of three-dimensional (3D) molecular structures, which allows for the finding and comparing of compounds with certain properties. As a result, it is frequently employed in the pharmaceutical business to find and develop innovative biotechnological products and processes.

One of the primary factors favorably impacting cheminformatics in anti-viral research or identifying medicines against the disease is the emergence of coronavirus (COVID-19). Aside from that, rising chronic disease cases and the resulting need for innovative medications are positively affecting market expansion. Increased investments in R&D initiatives drive demand for cheminformatics to validate new drug candidates and properly manage data generated during molecular and atomic reactions. Moreover, rising awareness of personalized medicine is propelling market development.

Key Players

MRFR recognizes the following companies as the key players in the global cheminformatics market— Agilent Technologies Inc, Bio-Rad Laboratories Inc, BioSolveIT GmbH, BIOVIA (Dassault Systèmes), ChemAxon Inc, Eurofins CEREP SA (Eurofins Panlabs Inc), Jubilant Biosys Inc, Molecular Discovery Ltd, OpenEye Scientific Software Inc, Schrödinger Inc.

Segment Analysis

The global cheminformatics market has been segmented based on application.

Based on application, the global cheminformatics market has been segmented into chemical analysis, drug discovery, drug validation, and others. The chemical analysis segment was expected to hold the largest market share in 2022.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Cheminformatics Market Research Report

Regional Analysis

Based on region, the global cheminformatics market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of US and Canada. The Europe cheminformatics market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The cheminformatics market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World cheminformatics market comprises the Middle East, Africa, and Latin America.

The North American regional sector continued to hold the largest revenue share of the global market for cheminformatics. North America, a mature market for cheminformatics, is experiencing steady growth, owing to factors such as a strong presence of leading market players, a well-developed healthcare infrastructure, and increased investments in R&D in the pharmaceutical and biotechnology sectors. Also, the region has a high adoption rate of sophisticated technologies and a clear regulatory framework, helping the growth of the North American cheminformatics market.

Moreover, the European cheminformatics market is continuously expanding, owing to a well-established pharmaceutical and chemical sector, increased research and development activities, and stringent drug discovery and development laws. Growing investments in developing innovative pharmaceuticals and personalized medicine in the region are boosting demand for cheminformatics solutions.

Asia Pacific is anticipated to experience rapid growth over the forecast period. This expansion can be ascribed to various factors, including increased spending in R&D operations in the pharmaceutical and chemical sectors, rising demand for personalized treatment, and the use of new technology in drug discovery procedures. In addition, chronic illness prevalence, rising healthcare expenditure, and expanding pharmaceutical manufacturing capabilities in nations such as China and India drive demand for cheminformatics tools in the region. A huge pool of trained labor, favorable government initiatives, and expanding collaborations between academics and businesses all further contribute to the rapid growth of the Asia-Pacific cheminformatics market.

Furthermore, other regions, including Latin America, the Middle East, and Africa, are also seeing an increase in demand for cheminformatics tools, owing to increased investments in healthcare infrastructure, increased awareness of personalized medicine, and a greater emphasis on drug research and development. However, these regions may face challenges related to limited resources and infrastructure, which could impact the growth of the cheminformatics industry to some extent.

Key Findings of the Study

• The global cheminformatics market is expected to reach USD 20.11 billion by 2032, at a CAGR of 15.5% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to rapid industrialization, growing healthcare spending, favorable government policies, the strong presence of key market players, and increasing awareness about the benefits of cheminformatics tools.


• Based on application, the chemical analysis segment was attributed to holding the largest market in 2022, with an approximate market share of 37%.


• Agilent Technologies Inc, Bio-Rad Laboratories Inc, BioSolveIT GmbH, BIOVIA (Dassault Systèmes), ChemAxon Inc, Eurofins CEREP SA (Eurofins Panlabs Inc), Jubilant Biosys Inc, Molecular Discovery Ltd, OpenEye Scientific Software Inc, Schrödinger Inc.